<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="367281">
  <stage>Registered</stage>
  <submitdate>19/10/2014</submitdate>
  <approvaldate>22/04/2015</approvaldate>
  <actrnumber>ACTRN12615000365561</actrnumber>
  <trial_identification>
    <studytitle>Perioperative calcium, magnesium and phosphorus levels in living donors for liver transplant</studytitle>
    <scientifictitle>Perioperative calcium, magnesium and phosphorus levels in living donors for liver transplant</scientifictitle>
    <utrn />
    <trialacronym>PELDLT</trialacronym>
    <secondaryid>Nil known</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Perioperative calcium, magnesium and phosphorus levels in living donors for liver transplant</healthcondition>
    <conditioncode>
      <conditioncode1>Surgery</conditioncode1>
      <conditioncode2>Other surgery</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>We will perform a retrospective analysis of the perioperative data of 44 donors who underwent right lobe hepatectomy for living related liver transplantation in our centre to characterize the incidence of hypocalcemia, hypomagnesemia and hypophosphatemia among this patient population. We will collect the following data: operative time, urine output, total amount of crystalloid and colloid administered, and the values of serum ionized calcium, magnesium and phosphorus at preoperative day and postoperative days 0, 1 and 2. The normal ranges of serum calcium, magnesium and phosphorus will be defined as 2.2-2.5 mmol/L, 0.7-1 mmol/L and 0.8-1.6 mmol/L respectively. the overall duration of observation in participants is 4 days (preoperative day and 3 days in intensive care).
</interventions>
    <comparator>we will compare between levels of calcium, magnesium and phosphorus during pre-operative period, day 0 post-operative, day 1 post-operative and day 2 post-operative in living donors underwent hepatectomy for liver transplantation. we will assess if there is significant difference between values.</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Not applicable</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Serum assay is used to detect if there is significant change in serum calcium level peri-operative in donors for living liver transplant</outcome>
      <timepoint>observational retrospective study; serum calcium is assessed on preoperative day and post-operative at day 0, 1 and 2.</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Serum assay is used to detect if there is significant change in serum magnesium level peri-operative in donors for living liver transplant</outcome>
      <timepoint>observational retrospective study; serum magnesium is assessed on preoperative day and postoperative at day 0,1 and 2.</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Serum assay is used to detect if there is significant change in serum phosphorus level peri-operative in donors for living liver transplant</outcome>
      <timepoint>observational retrospective study; serum phosphorus is assessed on preoperative day and on postoperative day 0,1 and 2.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>to detect any morbidity associated with change in serum level of electrolytes by electrocardiogram assessment for any arrythmias and clinical assessment for change in motor power of the patients</outcome>
      <timepoint>electrocardiogram and clinical assessment on post-operative at day 0, 1 and 2.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>- ASA physical status I.
- age 21-40 years.
- donors underwent hepatectomy for living liver transplantation.
</inclusivecriteria>
    <inclusiveminage>21</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>40</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>- ASA physical staus II or more.
- age more than 40 years old.
- patients who underwent massive intra-operative blood loss and required blood transfusion for rescucitation. 
- patients who required re-exploration for post-operative bleeding.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods>data are expressed as mean and chi-square-t test is used to compare between values (pre-operative, day 0, day 1 and day 2) </statisticalmethods>
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry>True</patientregistry>
    <followup>4</followup>
    <followuptype>Days</followuptype>
    <purposeobs>Screening</purposeobs>
    <duration>Cross-sectional</duration>
    <selection>Defined population</selection>
    <timing>Retrospective</timing>
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>15/09/2014</anticipatedstartdate>
    <actualstartdate>15/09/2014</actualstartdate>
    <anticipatedenddate>1/10/2014</anticipatedenddate>
    <actualenddate>1/10/2014</actualenddate>
    <samplesize>44</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Egypt</country>
      <state>cairo</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Ahmed Abdelaal Ahmed Mahmoud</primarysponsorname>
    <primarysponsoraddress>work organisation: Beni Suef University hospital
corresponding address:Egypt, cairo, nasr city, 7th district, 39 mousa ebn nousir street.
P.O. 11471</primarysponsoraddress>
    <primarysponsorcountry>Egypt</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname>Ahmed Abdelaal Ahmed Mahmoud</fundingname>
      <fundingaddress>Egypt, cairo, nasr city, 7th district, 39 mousa ebn nousir street.
P.O. 11471</fundingaddress>
      <fundingcountry>Egypt</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Mohamed Mohamed Abdelhaq</sponsorname>
      <sponsoraddress>work organisation: Beni Suef University hospital
corresponding address:Egypt, cairo, nasr city, 7th district, 39 mousa ebn nousir street.
P.O. 11471</sponsoraddress>
      <sponsorcountry>Egypt</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>We collected perioperative laboratory results of 44 living donors for liver transplantation in the period from February 2009 to August 2013; we analyzed results of perioperative calcium, magnesium and phosphorus levels at preoperative day, day 0, day 1 and day 2 postoperative.  </summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>research and ethics committee-faculty of medicine-beni suef university</ethicname>
      <ethicaddress>Egypt-Beni Suef governorate- Beni Suef university- faculty of medicine- mokbl street- P.O. 62511</ethicaddress>
      <ethicapprovaldate>14/09/2014</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate>1/09/2014</ethicsubmitdate>
      <ethiccountry>Egypt</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Ahmed Abdelaal Ahmed Mahmoud</name>
      <address>work organisation: Beni Suef University hospital
corresponding address:Egypt, cairo, nasr city, 7th district, 39 mousa ebn nousir street.
P.O. 11471</address>
      <phone>+20 1113308866</phone>
      <fax />
      <email>carnitin7@yahoo.com</email>
      <country>Egypt</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>mohamed mohamed abdelhaq</name>
      <address>work organisation: Cairo University hospital
corresponding address:EGYPT- Cairo- al manial- faculty of medicine- cairo university- department of anesthesia.</address>
      <phone>+20 1000053764</phone>
      <fax />
      <email>mohamedabdelhaq76@hotmail.com </email>
      <country>Egypt</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Ahmed Mostafa Alsharawy</name>
      <address>Egypt- Beni Suef governorate-Beni Suef city, Beni Suef University- faculty of medicine- department of anesthesia- 3 mokbl street, P.O. 62511</address>
      <phone>+20 1141015584</phone>
      <fax />
      <email>drshaarawy@yahoo.com</email>
      <country>Egypt</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>